The serotonin-7 receptor as a novel therapeutic target

Journal of Clinical Psychiatry

Volumn 71, Issue 11, 2010, Pages 1414-1415

  Stahl, Stephen M ^a,b,c  

^a NEUROSCIENCE EDUCATION INSTITUTE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMISULPRIDE; AMOXAPINE; ANTIDEPRESSANT AGENT; ARIPIPRAZOLE; ASENAPINE; CHLORPROMAZINE; CLOZAPINE; CYAMEMAZINE; DESIPRAMINE; FLUOXETINE; FLUPHENAZINE; ILOPERIDONE; IMIPRAMINE; LOXAPINE; LURASIDONE; MIANSERIN; PALIPERIDONE; PIMOZIDE; QUETIAPINE; RISPERIDONE; SEROTONIN 7 RECEPTOR; SEROTONIN UPTAKE INHIBITOR; SERTINDOLE; ZIPRASIDONE; ZOTEPINE;

CIRCADIAN RHYTHM; COGNITION; DEPRESSION; EXTRAPYRAMIDAL SYNDROME; HIPPOCAMPUS; HYPOTHALAMUS; INTERNEURON; LEARNING; MEMORY; MOOD; NONHUMAN; PRIORITY JOURNAL; RAPHE NUCLEUS; REVIEW; SCHIZOPHRENIA; SLEEP; SUPRACHIASMATIC NUCLEUS; THALAMUS; TRANQUILIZING ACTIVITY;

ANTIPSYCHOTIC AGENTS; DEPRESSIVE DISORDER; HUMANS; RECEPTORS, SEROTONIN; SEROTONIN ANTAGONISTS;

EID: 78649766286     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.10bs06601gry     Document Type: Review

References (18)

1. Stahl SM. Stahl's Essential Psychopharmacology. 3rd ed. New York, NY: Cambridge University Press; 2008.
2. Stahl SM. Stahl's Illustrated Antipsychotics. 2nd ed. New York, NY: Cambridge University Press; 2010.
3. 7 receptor and disorders of the nervous system: an overview. Psychopharmacology (Berl). 2009;206(3):345-354.
4. 3H]serotonin release in raphe nuclei slices of the rat: evidence for a serotonergic-glutamatergic interaction. Neurochem Res. 2004;29(8):1487-1497.
5. 7 receptors enhances 5-HT transmission, antidepressant-like behavior, and rapid eye movement sleep suppression induced by citalopram in rodents. J Pharmacol Exp Ther. 2007;321(2):690-698.
6. Cuesta M, Clesse D, Pévet P, et al. New light on the serotonergic paradox in the rat circadian system. J Neurochem. 2009;110(1): 231-243.
7. Hedlund PB, Sutcliffe JG. Functional, molecular and pharmacological advances in 5-HT7 receptor research. Trends Pharmacol Sci. 2004;25(9):481-486.
8. 7 receptor as a mediator and modulator of antidepressant-like behavior. Behav Brain Res. 2010;209(1):99-108.
9. 7 receptor is involved in allocentric spatial memory information processing. Behav Brain Res. 2009;202(1):26-31.
10. Monsma FJ Jr, Shen Y, Ward RP, et al. Cloning and expression of a novel serotonin receptor with high affinity for tricyclic psychotropic drugs. Mol Pharmacol. 1993;43(3):320-327. PubMed (Pubitemid 23081986)
11. 7 receptor regulation in the rat hypothalamus. Neuropsychopharmacology. 1999;21(3):352-367.
12. Roth BL, Craigo SC, Choudhary MS, et al. Binding of typical and atypical antipsychotic agents to 5-hydroxytryptamine-6 and 5-hydroxytryptamine-7 receptors. J Pharmacol Exp Ther. 1994;268(3):1403-1410.
13. Shapiro DA, Renock S, Arrington E, et al. Aripiprazole, a novel atypical antipsychotic drug with a unique and robust pharmacology. Neuropsychopharmacology. 2003;28(8):1400-1411.
14. Lawler CP, Prioleau C, Lewis MM, et al. Interactions of the novel antipsychotic aripiprazole (OPC-14597) with dopamine and serotonin receptor subtypes. Neuropsychopharmacology. 1999;20(6):612-627.
15. 1A receptor activity. J Pharmacol Exp Ther. 2010;334(1):171-181.
16. Abbas AI, Hedlund PB, Huang X-P, et al. Amisulpride is a potent 5-HT7 antagonist: relevance for antidepressant actions in vivo. Psychopharmacology (Berl). 2009;205(1):119-128.
17. Smith C, Rahman T, Toohey N, et al. Risperidone irreversibly binds to and inactivates the h5-HT7 serotonin receptor. Mol Pharmacol. 2006;70(4):1264-1270.
18. Stahl SM, Fava M, Trivedi MH, et al. Agomelatine in the treatment of major depressive disorder: an 8-week, multicenter, randomized, placebo-controlled trial. J Clin Psychiatry. 2010;71(5):616-626.